(Q45738786)

15 December 2017

title

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection (English)

1 reference

15 December 2017

1 reference

end-stage liver disease

1 reference

Bica I

1

1 reference

15 December 2017

McGovern B

2

1 reference

15 December 2017

Dhar R

3

1 reference

15 December 2017

Stone D

4

1 reference

15 December 2017

McGowan K

5

1 reference

15 December 2017

Scheib R

6

1 reference

15 December 2017

Snydman DR

7

1 reference

15 December 2017

language of work or name

English

0 references

publication date

23 January 2001

1 reference

Clinical Infectious Diseases

15 December 2017

published in

1 reference

15 December 2017

volume

32

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

492-497

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

15 December 2017

cites work

1 reference

Hepatitis C Virus Infection in Patients Infected with the Human Immunodeficiency Virus

21 January 2018

1 reference

Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort).

21 January 2018

1 reference

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients

21 January 2018

1 reference

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

21 January 2018

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

21 January 2018

1 reference

Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy

21 January 2018

1 reference

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

21 January 2018

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

21 January 2018

1 reference

HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/318501

1 reference

15 December 2017

1 reference